dsRNA Control Strategies

• 

  Advancements in dsRNA-based Therapies for Disease Treatmen

  DSRNA is also being utilized for developing novel therapeutics for several other diseases besides gene editing. DsRNA is being used to research diseases such as diabetes, Parkinsons disease, and ALS. As scientists do more research and development, dsRNA may transform how we treat and even cure many of the diseases that impact people every day.

• 

  Unlocking the Potential of dsRNA for Agricultural and Biotech Industries

  For instance, dsRNA can be used to control plant viruses in agriculture. Scientists were able to specifically inhibit these parts of the virus with dsRNA to avoid healthy plants contracting the viruses. This is important, as plant viruses can ravage crops and cause food shortages that could impact people around the globe.

• 

  Engineering dsRNA for Enhanced Cellular Uptake and Efficacy

  In addition, dsRNA is being utilized to develop new and better crops. dsRNA can be used by scientists to create crops with greater resistance to pests and diseases. These genes guide the growth of plants, meaning that scientists can edit them to make these crops stronger and more food-rich to help feed our increasingly-growing planet.

Why choose Yaohai dsRNA Control Strategies?

• Personalización, eficiencia y rentabilidad

  Yaohai Bio-Pharma is dsRNA Control Strategies in microbial-derived biologics. We offer custom RD as well as manufacturing solutions, while minimising the risk. We've been involved in numerous modalities like recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies, enzymes, plasmid DNA, the mRNA, and other. We are experts in several Microbial hosts, such as yeast extracellular and intracellular (yield up to 15 grams per liter) bacteria periplasmic secretion as well as soluble intracellular inclusion bodies (yield up to 10 grams/L). Additionally, we have developed the BSL-2 microbial fermentation platform for the development of bacterial vaccines. We have a track record of improving production processes, thereby increasing yields, and reducing costs. With a highly efficient technology team, we guarantee prompt and reliable project delivery and bring your products to market quicker.

• Sistema de Calidad y Cumplimiento Normativo Global

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality management and regulatory issues. We have developed a solid quality management system that conforms to the current GMP standards and regulations globally. Our regulatory team has an in-depth understanding of the world-wide regulatory frameworks. This allows us to accelerate biological launches. We ensure traceable production processes as well as high-quality products and in compliance with the guidelines of the US FDA and EU EMA. dsRNA Control Strategies and China NMPA are also satisfied. Yaohai BioPharma successfully passed an on-site audit conducted by an accredited Qualified Person of the European Union (QP) to review our GMP system and production facility. We have also been through the first certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Cadena de suministro y capacidades de fabricación sólidas

  Yaohai Bio-Pharma, a top 10 dsRNA Control Strategies of biological products, is a specialist in microbial fermentation. We have set up a modern facility that has robust RD capabilities and advanced infrastructure. Five lines of production for drugs conforming to GMP standards to purify and ferment microbial cells along with two fill and finish lines for vials as well as cartridges and needles pre-filled are readily available. The fermentation scales available for use range from 100L to 2000L. Filling specifications for vias are 1ml to 25ml, whereas pre-filled syringe or cartridge filling requirements are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. The large molecules manufactured in our facility are available for delivery worldwide.

• Experiencia profesional y amplia experiencia

  Yaohai Bio-Pharma is a leading in microbial biologics CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to manage the health of pets, humans and animals. health. We have modern RD and manufacturing technology platforms that cover the entire process, from microbial strain engineering, cell banking, process and method design to commercial and clinical manufacturing, which ensures the success supply of the most cutting-edge solutions. Through the years we have gained vast expertise in using microbial sources. Over 200 projects were successfully completed. In addition, we support our clients in get through regulations, such as those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. Our expert knowledge and vast experience allow us to quickly respond to market demands and provide dsRNA Control Strategies CDMO services.

Categorías de productos relacionados

• Métodos analíticos para el ADN plásmido
• Fabricación de VLP del bacteriófago AP205
• Fabricación de VLP del bacteriófago Q
• Fabricación de vacunas VLP quiméricas
• Fabricación de vacunas VLP conjugadas
• Fabricación de vacunas de ADN
• Fermentación de E. coli para la producción de VLP
• Fabricación de agonistas de GLP-1
• Fabricación analógica GLP-1
• Producción de fragmentos de GLP-1

¿No encuentras lo que estás buscando?
Póngase en contacto con nuestros consultores para obtener más productos disponibles.